metadata toggle
Clinical particulars
Target species
Pigs
Indications for use, specifying the target species
For the active immunisation of pigs as an aid to control pleuropneumonia caused by Actinobacillus pleuropneumoniae serotypes 1 and 2, by reducing the clinical signs and lung lesions associated with the disease.
Onset of immunity: 21 days following second vaccination
Duration of immunity: 16 weeks following second vaccination
Contraindications
None.
Special warnings for each target species
No information is available on the efficacy of the vaccine in animals with maternally derived antibodies. However, these antibodies are usually not present in piglets at the age of vaccination.
Vaccinate healthy animals only
Special precautions for use
Special precautions for use in animals
Not applicable
Special precautions to be taken by the person administering the veterinary medicinal product to animals
In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician.
Adverse reactions (frequency and seriousness)
Adverse reactions to the vaccine include:
- a transient and mild swelling of maximum 2x3.2 cm is very common at the site of injection, persisting for at least 8 days.
- body temperature commonly increases by up to 1.8°C for 2 hours on days 1 or 2 after vaccination
Vaccinated pigs may show signs of prostration for a few hours after vaccination; however, this is uncommon.
Anaphylactic type reactions have been very rarely reported and appropriate symptomatic treatment is recommended.
Use during pregnancy, lactation or lay
Do not use during pregnancy and lactation.
Interaction with other medicinal products and other forms of interaction
No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.
Amounts to be administered and administration route
Intramuscular use. The preferred site of administration is the neck region.
Dose: 2 ml
Vaccination schedule: 2 doses administered to animals from 7 weeks of age with an interval of 3 weeks between doses.
Shake well before use.
Use sterile syringe and needle, respect aseptic conditions of vaccination.
Overdose (symptoms, emergency procedures, antidotes), if necessary
Administration of a double dose caused no other reactions than those described in section Adverse reactions; however, severity of the signs was increased e.g. transient and mild swelling of maximum 3x3 cm at the site of injection, regressing but persisting for at least 14 days; body temperature increases of up to 2.6°C for 2 hours on days 1 or 2 after vaccination.
Withdrawal period
Zero days.